文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

孕前奥利司他治疗对超重/肥胖女性体外受精结局影响的随机对照试验研究方案

Effect of preconceptional orlistat treatment on in-vitro fertilization outcome in overweight/obese women: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-07-18

本研究为多中心、随机、安慰剂对照、双盲临床试验,纳入20-40岁接受体外受精-胚胎移植(IVF-ET)的超重/肥胖女性,评估IVF-ET前1-3个月奥利司他治疗能否提高活产率。主要结局为活产,结果将为孕前奥利司他治疗对超重/肥胖女性IVF结局的影响提供证据。

要点

  • 肥胖女性ART后获卵数少、取消率高、流产率高、活产率低。
  • 孕前减重可显著改善妊娠率和/或活产率。
  • 奥利司他联合饮食可促进减重,但缺乏随机对照试验证据。

核心结论

  • 本研究旨在评估IVF-ET前1-3个月奥利司他治疗能否提高超重/肥胖女性的活产率。

研究设计与样本

  • 多中心、随机、安慰剂对照、双盲临床试验,纳入20-40岁接受IVF-ET(伴或不伴卵胞浆内单精子注射)的超重/肥胖女性。

关键数值与推荐

  • 主要结局为活产。
  • 奥利司他治疗时间为IVF-ET前1-3个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obese women have fewer oocytes retrieved, an increased cancelation rate, a higher miscarriage rate, and a lower live birth rate after assisted reproductive technology (ART) treatment compared with women with normal weight. Weight loss before ART treatment can significantly improve pregnancy rates and/or live births. An orlistat plus diet intervention could promote weight loss, but there is no evidence from randomized clinical trials evaluating the effect of orlistat preconceptional treatment on pregnancy outcome in overweight and obese women. METHODS/DESIGN: We are conducting a multicenter, randomized placebo-controlled, double-blind clinical trial in overweight and obese women aged 20-40 years undergoing in-vitro fertilization and embryo transfer (IVF-ET) with or without intracytoplasmic sperm injection, to evaluate whether orlistat treatment for 1-3 months before IVF-ET can improve the live birth rate. The primary outcome is live birth. DISCUSSION: The results of this study will provide evidence for the effect of preconceptional orlistat treatment on IVF outcome in overweight/obese women. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IPR-17011629 . Registered on 11 June 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li J, Wang Z, Wei D, et al. Effect of preconceptional orlistat treatment on in-vitro fertilization outcome in overweight/obese women: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30021634. doi:10.1186/s13063-018-2780-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。